Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.89
+0.17 (2.20%)
May 21, 2026, 12:23 PM EDT - Market open
Ginkgo Bioworks Holdings Revenue
Ginkgo Bioworks Holdings had revenue of $19.47M in the quarter ending March 31, 2026, a decrease of -49.06%. This brings the company's revenue in the last twelve months to $121.84M, down -35.57% year-over-year. In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%.
Revenue (ttm)
$121.84M
Revenue Growth
-35.57%
P/S Ratio
3.33
Revenue / Employee
$312,163
Employees
485
Market Cap
515.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 170.16M | -56.89M | -25.06% |
| Dec 31, 2024 | 227.04M | -24.41M | -9.71% |
| Dec 31, 2023 | 251.46M | -226.25M | -47.36% |
| Dec 31, 2022 | 477.71M | 163.87M | 52.21% |
| Dec 31, 2021 | 313.84M | 237.18M | 309.40% |
| Dec 31, 2020 | 76.66M | 22.47M | 41.48% |
| Dec 31, 2019 | 54.18M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionDNA News
- 11 days ago - Ginkgo Bioworks Q1 Earnings Call Highlights - MarketBeat
- 13 days ago - Ginkgo Bioworks reaffirms 2026 expected total cash burn of ($150M)-($125M) - TheFly
- 13 days ago - Ginkgo Bioworks Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 13 days ago - Ginkgo Bioworks Holdings Earnings release: Q1 2026 - Filings
- 13 days ago - Ginkgo Bioworks Holdings Quarterly report: Q1 2026 - Filings
- 13 days ago - Ginkgo Bioworks Holdings Slides: Q1 2026 - Filings
- 13 days ago - Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab - PRNewsWire
- 21 days ago - Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation - PRNewsWire